Formosa Pharmaceuticals (TPE:6838) Ending Cash Position : NT$514.6 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Formosa Pharmaceuticals Ending Cash Position?

Formosa Pharmaceuticals's Ending Cash Position for the quarter that ended in Sep. 2024 was NT$514.6 Mil.

Formosa Pharmaceuticals's quarterly Ending Cash Position declined from Mar. 2024 (NT$309.4 Mil) to Jun. 2024 (NT$167.1 Mil) but then increased from Jun. 2024 (NT$167.1 Mil) to Sep. 2024 (NT$514.6 Mil).

Formosa Pharmaceuticals's annual Ending Cash Position increased from Dec. 2021 (NT$208.9 Mil) to Dec. 2022 (NT$267.3 Mil) and increased from Dec. 2022 (NT$267.3 Mil) to Dec. 2023 (NT$384.7 Mil).

Formosa Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for Formosa Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Formosa Pharmaceuticals Ending Cash Position Chart

Formosa Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

77.27

41.87

208.92

267.34

384.71

Formosa Pharmaceuticals Quarterly Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Ending Cash Position	Get a 7-Day Free Trial										425.57	384.71	309.44	167.06	514.62

Formosa Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Formosa Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	267.338	+	117.367
	=	384.7

Formosa Pharmaceuticals's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	167.062	+	347.553
	=	514.6

Formosa Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Formosa Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Formosa Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Formosa Pharmaceuticals Inc (TPE:6838) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 57, Fuxing North Road, 8th Floor 6, Songshan District, Taipei, TWN, 105

Website

https://www.formosapharma.com

Formosa Pharmaceuticals Inc is a late-preclinical and early-clinical stage biopharmaceutical company with focus in the indications of ophthalmology, oncology, and anti-infectives.

Formosa Pharmaceuticals Headlines

No Headlines